|Articles|July 13, 2022
Signant Health Enhances Randomization and Trial Supply Management (RTSM) Platform
RTSM solution now offers additional benefits with the delivery of study supplies to patients' homes.
Advertisement
Signant Health has announced enhancements to its Randomization and Trial Supply Management (RTSM) platform to enable direct-to-patient clinical supply distribution.
The enhancements to Signant's RTSM solution enable secure and encrypted storage of patient shipment addresses, integration with depot/central pharmacy ordering systems, and courier status reporting.
Read more about the platform
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
Controlled Clinical Trials in Sub-Saharan Africa: A Winning Value Proposition
3
ACT Brief: FDA Approval of Oral Wegovy, 2025’s Most-Read ACT Coverage, and Data Quality as the Foundation for AI
4
ACT Brief: Building a Digital Thread in Life Sciences, CRO Sourcing Decisions and Site Burden, and Lilly’s Oral GLP-1 Phase III Results
5